St. Jude Claims 3-Point ICD Market Share Gain Since CRT Competition Began

CMS' decision to limit prophylactic ICD coverage to patients with a QRS duration of over 0.12 seconds will increase demand for cardiac resynchronization therapy (CRT) ICDs at the expense of conventional implantable defibrillators, St. Jude Medical maintains